Appointment of Mr. Shashank Srowthy as Executive Director and Chief Financial Officer of the Company, effective October 1, 2025 in place of Mr. Lokesh Chandak.

pdf

Procter & Gamble Health Ltd.

08 Sep 2025

6288.50

-1.25%

Company Update

Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Dear Sir, Please find attached intimation regarding change in senior management personnel of the Company

pdf

Procter & Gamble Health Ltd.

01 Sep 2025

6288.50

-1.25%

Company Update

Procter & Gamble Health Ltd - 500126 - Change In Senior Management Personnel Of The Company

BSE India

Pursuant to Reg. 30 of the SEBI LODR, we hereby inform you that Mr. Ketan Kotadiya has been appointed as Head- Medical, Regulatory and R&D effective September 1, 2025.

pdf

Procter & Gamble Health Ltd.

29 Aug 2025

6288.50

-1.25%

AGM

Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Please find attached proceedings of the annual general meeting held for financial year 2024-25

pdf

Procter & Gamble Health Ltd.

29 Aug 2025

6288.50

-1.25%

AGM

Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Dear Sir, Please find attached voting results for the resolutions proposed to be passed at the Annual General meeting held today, along with scrutinizers report thereon.

pdf

Procter & Gamble Health Ltd.

26 Aug 2025, 12:04AM

6288.50

-1.25%

Company Update

Procter & Gamble Health Ltd - 500126 - Intimation Regarding IEPF''s 100 Days Campaign - 'Saksham …

BSE India

Dear Sir, Please find attached intimation regarding IEPF''s 100 days campaign.

pdf

Procter & Gamble Health Ltd.

26 Aug 2025, 12:02AM

6288.50

-1.25%

Corp. Note

Procter & Gamble Health Ltd - 500126 - Reg. 34 (1) Annual Report.

BSE India

Dear Sir/Madam, Please find attached letter for re-submission of annual report, to reflect the same under regulation 34(1) compliance. Same was submitted earlier, on August 6th, as per applicable timelines to the Company. There is no change in the version of the report.

pdf

Procter & Gamble Health Ltd.

18 Aug 2025

6288.50

-1.25%

Company Update

Procter & Gamble Health Ltd - 500126 - Approval Of Promoter Reclassification Pursuant To Company''s Application …

BSE India

Dear Sir, Please note that the stock exchanges have today, approved the reclassification of Company''s promoters, pursuant to Company''s application dated June 27, 2018. Further details are mentioned in attached letter. Please take note of the same.

pdf

Is Procter & Gamble Health Ltd. worth buying?

224 Votes:

Buy 72.77%

Sell 17.86%

Hold 9.38%